Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Common Stock Issued (2025 - 2026)

Updated

Impact Biomedical (IBO) reported Common Stock Issued of $1,000 for Q3 2026.

Analysis

Impact Biomedical (IBO) Common Stock Issued (2025 - 2026) Analysis & Trends

For FY2024, Impact Biomedical posted Common Stock Issued of $3.73 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 743.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 87.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1,000.00
Dec 31, 2025 1,000.00
API Access

Impact Biomedical Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=IBO&period=max&api_key=YOUR_API_KEY